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Abstract
Complement receptors CR3 (CD11b/CD18) and CR4 (CD11c/CD18) belong to the family
of beta2 integrins and are expressed mainly by myeloid cell types in humans. Previously,
we proved that CR3 rather than CR4 plays a key role in phagocytosis. Here we analysed
how CD11b and CD11c participate in cell adhesion to fibrinogen, a common ligand of CR3
and CR4, employing human monocytes, monocyte-derived macrophages (MDMs) and
monocyte-derived dendritic cells (MDDCs) highly expressing CD11b as well as CD11c. We
determined the exact numbers of CD11b and CD11c on these cell types by a bead-based
technique, and found that the ratio of CD11b/CD11c is 1.2 for MDDCs, 1.7 for MDMs and
7.1 for monocytes, suggesting that the function of CD11c is preponderant in MDDCs and
less pronounced in monocytes. Applying state-of-the-art biophysical techniques, we proved
that cellular adherence to fibrinogen is dominated by CD11c. Furthermore, we found that
blocking CD11b significantly enhances the attachment of MDDCs and MDMs to fibrinogen,
demonstrating a competition between CD11b and CD11c for this ligand. On the basis of the
cell surface receptor numbers and the measured adhesion strength we set up a model,
which explains the different behavior of the three cell types.
Introduction
Monocytes, macrophages and dendritic cells are phagocytes, which are able to adhere to extra-
cellular matrix components (e.g. fibrinogen) via different integrinmolecules. Integrins are het-
erodimeric transmembrane glycoproteins consisting of a non-covalently coupled alpha and
beta chain [1]. These moleculesmediate several functions that are associated with cytoskeleton
rearrangements, including cell-to-cell and cell-ECM contacts, proliferation, phagocytosis and
transendothelialmigration of immune cells [1–4]. The most abundant integrins expressed by
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cells of the monocytic linage are complement receptors (CR) CR3 (CD11b/CD18) and CR4
(CD11c/CD18), which are members of the β2 integrin family. The main natural ligand of CR3
and CR4 is iC3b, the inactivated fragment of C3, the central complement component [5], how-
ever, they bind several other molecules in common, like fibrinogen, ICAM-1, factor X, etc.
[6–11].
In humans, CR3 and CR4 are simultaneously expressed in monocytes,macrophages, den-
dritic cells, neutrophil granulocytes (PMNs) and NK cells. Since the main ligand of CR3 and
CR4 is identical, the study of the individual function of these integrins is challenging. In con-
trast to the human system, murine CD11c/CD18 expression is mainly limited to dendritic cells,
therefore CR4 can be used to identify this cell population. Furthermore the function as well as
signal transductionmediated by mouse CR3 can be separately studied [12–15]. Results
obtained in studies on mouse CD11b/CD18 however cannot be simply translated to the
human system, due to the previously mentioned differences between the two species. Our goal
is to dissect and determine the individual functional properties of human CR3 (CD11b/CD18)
and CR4 (CD11c/CD18).
Earlier we demonstrated that CR3 plays a key role in the phagocytosis of iC3b-opsonized
microbes by human MDDCs, while their maturation and inflammatory cytokine production is
not influenced by iC3b or CD11b specific antibody [16, 17]. We also examined the role of
CD11c/CD18 in the complement mediated phagocytosis of MDDCs, and found it dispensable
in this process, proving that the function of CR3 and CR4 is not identical. The aim of the pres-
ent work is to determine the participation of CR3 and CR4 in a different function linked to β2
integrins; namely cellular adhesion. The absolute numbers and the conformational state of
CR3 and CR4 expressed by the cells were assessed and the adherence of normal human mono-
cytes, MDDCs and MDMs to fibrinogenwas investigated. The strength and the kinetics of
adherence were estimated using classical and state-of-the-art biophysical methods. Our results
provide further evidence that human CR3 and CR4 are involved in different cellular functions
—despite their capacity to bind the same ligands.
Results
Absolute number and conformation analysis of CD11b/CD18 and
CD11c/CD18 on monocytes, MDMs and MDDCs
Our aim was to compare the role of CD11b and CD11c in adhesion to fibrinogen on mono-
cytes, MDMs and MDDCs. To achieve this goal, first we had to assess the exact number of the
receptors expressed by the cells, which has not been determined in a comprehensive manner so
far. To this end we used Qifikit (Dako), a bead based flow cytometric technique, which enables
the determination of absolute receptor numbers. Althoughmonocytes,macrophages and den-
dritic cells are thought to express CD11b and CD11c in similarly high amounts, precise num-
bers assessed by us show significant differences. The number of CD11bmolecules on the cell
surface is 247174+/-21281 for MDDCs, 309753+/-62045 for MDMs and 49831+/-7810 for
CD14+monocytes. Assessing CD11c expression we detected 203996+/-24623 for MDDCs,
185357+/-40160 for MDMs and 6972+/-2972 for CD14+monocytes (Fig 1A). We also calcu-
lated the CD11b:CD11c ratio on these cell types, and found 1,2 for MDDCs 1,7 for MDMs and
7,1 for monocytes. Namely, the relative amount of CD11c to CD11b is the highest in the case
of MDDCs intermediate on MDMs and the lowest on monocytes. This suggests that the func-
tions mediated by CD11c are the most instrumental in the case of MDDCs.
Since ligand binding by integrins is under conformational regulation, and only the open
form is known to be active [18], next we examined the conformational state of the receptors.
Monocytes, MDDCs and MDMs were stained at 4°C or 37°C with mAb24 that recognizes the
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active conformation of CD18, the common β2 chain in CR3 and CR4.We found that all cell
types are able to bind mAb24 at 37°C, and to a smaller extent at 4°C. The difference was statis-
tically not significant in neither of the cases when analysed by paired t-test. Nevertheless these
data clearly show that CR3 and CR4 are in a conformation capable of ligand binding on the
surface of monocytes,MDDCs and MDMs (Fig 1B).
Analysis of adhesion to fibrinogen using classical methods
To study the individual role of CD11b/CD18 and CD11c/CD18 in the adhesion to fibrinogen
we blocked either CD11b or CD11c by ligand binding site specificmonoclonal antibodies.
Unspecific binding of the antibodies was prevented by adding FcR blocking reagent to all the
samples (including controls), and the number of adhered cells was determined as percentage of
untreated control samples. Furthermore, treatment with isotypematched control mAbs did
not interfere with the adhesion of each cell type to fibrinogen.As shown in Fig 2A, blocking
CD11c decreased the number of adheringMDDCs and monocytes significantly, and slightly
(not significantly) blocked the adherence of MDMs. Blocking CD11b had no effect on MDMs
and MDDCs, however decreased the number of adheredmonocytes slightly (not significantly).
Next we aimed to determine how blocking of CD11b/CD18 or CD11c/CD18 receptors
affects the properties of adhesion to fibrinogen. To this end we analysed the contact area of the
differently treatedMDMs, MDDCs and monocytes by confocalmicroscopy. Actin cytoskeleton
and nuclei were stained, and 0,42 μm optical sections of the contact zone were analysed. Fig 2B
shows that blocking CD11b on MDMs results in larger contact areas, while blocking CD11c
decreases them compared to untreated samples. In the case of MDDCs inhibition of CD11b
induced a more polarized and slightly larger contact surface, while anti-CD11c treated cells
showed a round shape, but similar contact area to control cells. Monocytes are smaller than
MDMs and MDDCs, therefore their contact zone is also smaller, as seen in Fig 2B. Blocking of
Fig 1. Expression and conformation of CD11b and CD11c. (A) The exact amount of CD11b and CD11c on the surface of monocyte-
derived dendritic cells (MDDC), monocyte-derived macrophages (MDM) and monocytes were determined using Qifikit (Dako) as
described in Materials and methods. Data presented are mean +/-SD of three independent donors’ results. (B) Cells were stained with
monoclonal antibody mAb24 that is specific for the high affinity conformation of CD18. Relative mean fluorescence intensity (RMFI) was
calculated in each case by comparing the signal of mAb24 stained cells to isotype matched control antibody stained cells (RMFI = MFI
mAb24/MFI isotype control). At 4˚C RMFI values were around 1 (monocytes: 0,60+/-0,22; MDDC: 1,50+/-0,20; MDM: 0,97+/-0,91),
meaning that cells do not have active β2 integrins on their surface. At 37˚C all cell types bound mAb24 (RMFI for monocytes: 2,05+/-0,93;
MDDC: 5,07+/-3,15; MDM: 1,87+/-1,42) showing that β2 integrins were in a conformation capable of ligand binding on their surface. Data
presented are mean +/-SD of three independent donors’ results.
doi:10.1371/journal.pone.0163120.g001
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CD11b caused an increased contact area also in the case of monocytes, in contrast to inhibition
of CD11c, which had no effect.
To quantify these observations, we established different categories based on the contact size
of the cells. Namely we defined 3 categories for MDMs and MDDCs and 2 for monocytes (Fig
3A–3C), and determined their proportion. By blocking CD11b, cells with small contact area
almost completely disappeared in the case of MDMs and MDDCs, and their proportion
decreased in the sample of monocytes. Simultaneously, the ratio of spread-out cells increased
Fig 2. Number and contact zone structure of cells after blocking CD11b or CD11c with antibodies. Cells were treated with
monoclonal anti-CD11b or anti-CD11c antibodies on ice for 30 min or left untreated for control. The Fc receptor blocking reagent was
used prior adding the antibodies in all samples. Cells were let to adhere for 30min at 37˚C 5%CO2 on plates coated previously with
10μg/ml fibrinogen and blocked with PLL-g-PEG. After that cells were fixed with 2% paraformaldehyde for 10min, and washed twice
with PBS to remove unbound cells. Nuclei were stained with Draq5 and actin cytoskeleton with phalloidin-Alexa488 probe. (A) The
number of adhered cells was determined by analysing 12 representative fields after each treatment using Olympus IX81 microscope
at 10x magnification. The number of adherent cells in control samples was taken 100%, and the effect of different treatments was
compared to it. Mean +/- SD of three independent donors’ results is shown. Repeated measures ANOVA with Bonferroni post-test
was used to determine significant differences compared to control * = p<0,05 (B) A 0,42 μm slice of the contact zone was analysed by
60x magnification. Red fluorescence shows cell nuclei (Draq5), green shows filamentous actin (phalloidine-Alexa488).
doi:10.1371/journal.pone.0163120.g002
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Fig 3. Contact zone size of cells after blocking CD11b or CD11c with antibodies. Cells were divided
into categories based on the size of their contact zones. MDMs (A) and MDDCs (B) were categorised into
the following three groups: small2000 pixel2, medium 2000–400 pixel2, large4000 pixel2. For monocytes
(c) only 2 categories were established because of their smaller size (small1000 pixel2, large> 100 pixel2).
200 cells were counted for each cell type and each treatment, and the distribution between the different
contact size categories was determined and is shown for MDDCs (D), MDMs (E) and monocytes (F). Results
of one representative experiment of three independent ones is shown.
doi:10.1371/journal.pone.0163120.g003
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in the case of all cell types, showing that CD11b acts against spreading. On the contrary, block-
ing CD11c elevated the ratio of cells with small contact area in MDMs and the ratio of medium
area cells in MDDCs, but had no effect on monocytes (Fig 3D–3F).
Analysis of adhesion force using computer controlled micropipette
To further characterise the role of CD11b/CD18 and CD11c/CD18 in cell adhesion to fibrino-
gen, we performed state-of-the-art biophysical measurements on differently treated cells. Cells
were let to adhere on fibrinogen coat, and their adhesion force was assessed by trying to pick
them up with a computer controlled micropipette using vacuum assisted fluid flow. The pick-
up process was repeated several times with increasing the vacuum, and cells remaining on the
surface were counted after each cycle. Applied vacuumwas converted to force (μN) on the
basis of computer simulations, and experimental data are presented as the ratio of differently
treated adherent cells compared to the untreated control. Using this method we observed that
blocking CD11b increased the force of adhesion of MDDCs significantly and elevated the force
of adhesion in the case of MDMs (not significant, Fig 4A and 4B), however, it significantly
decreased the strength of adhesion in the case of monocytes (Fig 4C). The significant strength-
ening and decreasing effect was observed among the cells that adhered the strongest. This is in
good concordance with our previous results showing that anti-CD11b treatment slightly
reduces the number of adhesive monocytes (Fig 2A). This treatment also increased the propor-
tion of cells with medium and large contact area (Fig 3). Blocking CD11c decreased the adhe-
sion force in each cell type, underlining the importance of this receptor in the process, however
the differences were not found to be significant.
Analysis of adhesion kinetics using optical waveguide biosensor
To perform kinetic studies on adherence to fibrinogen, the EPIC label free optical biosensor
was used. This method enables the real-timemonitoring of a 100–200 nm width layer over the
adhesive surface by analysing the refractive index alterations in this volume. Cells can reach
this area only by adhesion, thereby non adhering cells are excluded from the measurement. Sig-
nal is detected as the shift of resonant wavelength (Δλ). The higher this shift, the larger area of
the sensor is covered or the stronger the contact between the cells and their substrate. This
means that using this method we detect a combined signal of the number of the adhered cells
and the size and density of their contact area [19, 20]. The experiment was performed on
MDMs, where the expression of CD11b or CD11c was downregulated using RNA silencing.
For control, cells were transfected with negative control siRNA. To avoid the undesired contri-
bution of unbound antibodies to the optical sensor antibody blocking was not used in this
method. Fig 5A shows a representative graph, where CD11b silenced cells show higher, and
CD11c silenced cells lower signal, as compared to the control sample. Since cells were let to
adhere for 30 minutes in the case of the other methods used by us, we determined the mean Δλ
value for 3 independent experiments at the 30th minute of the kinetic experiment. Data
obtained confirm our previous findings, namely, that blocking CD11c decreased the adhesive
capacity of the cells significantly while blocking CD11b elevated it slightly (not significantly)
(Fig 5B). To validate the results obtained with RNA silenced cells, we assessed their adhesion
profile employing two furthermethods, too. We analysed the actin clusters of the contact zone
in confocal microscope, and found that CD11b silencedMDMs had stronger actin clusters
than the control cells, and significantlymore than the CD11c silenced cells had. The opposite
was true for the weak actin clusters; CD11c silenced cells had significantlymore of that than
the CD11b silenced cells (Fig 5C). The computer controlled micropipette confirmed these
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Fig 4. Force of cell adhesion after blocking CD11b or CD11c with antibodies. MDDCs (A), MDMs (B)
and monocytes (C) were treated with monoclonal anti-CD11b or anti-CD11c antibodies on ice for 30 min or
left untreated for control. The Fc receptor blocking agent was used prior adding the antibodies in all samples.
Cells were let to adhere for 30min at 37˚C 5%CO2 in Petri dishes coated previously with 10μg/ml fibrinogen
and blocked with PLL-g-PEG. After that cells were gently washed twice with PBS to remove unbound cells.
The number of adhered cells was determined in the field of the microscope and is shown as 0,00μN. The
computer controlled micropipette made serial pick-up processes in the field by using increasing amount of
vacuum. A microscopic picture was taken after each round and the number of remaining cells was
CD11c/CD18 Dominates Adhesion over CD11b/CD18
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results (Fig 5D) showing that RNA silencing caused similar changes in the cells’ adhesive
capacity as receptor blocking with antibodies.
Discussion
The family of β2 integrins consists of four members: CD11a/CD18 (LFA-1), CD11b/CD18
(CR3, Mac-1), CD11c/CD18 (CR4, p150/95) and CD11d/CD18. The role of LFA-1 in lympho-
cyte trafficking is well characterised, however, the role of CD11d/CD18 is still unexplored [21].
Although the function of CD11b/CD18 and CD11c/CD18 is being investigated for long, dis-
secting their individual role is technically challenging for many reasons. It is important to
emphasize that their expression pattern is fundamentally different in mice and men. In the
mouse CD11b is expressed on all myeloid cells, while CD11c is present mainly on dendritic
cells. Due to this differential expression in mice signal transduction via CD11b/CD18 is well
characterized [13, 15] but is not fully known in the case of the other β2 integrins. Activation of
β2 integrins was shown to be linked to Src family kinases Hck and Fgr further leading to Syk
signalling via DAP12, the adaptor molecule in murine neutrophils and macrophages [13,
14, 22].
In contrast to mice, in humans CD11b and CD11c are simultaneously expressed on a wide
variety of myeloid cells, as well as on certain populations of lymphoid cells [8, 23, 24]. What
makes their analysis even more challenging is their overlapping ligand specificity. They have
several common ligands, including inactivated C3b fragment (iC3b), fibrinogen and ICAM-1
[6, 10, 11, 25–27], and due to this it has been postulated that the function of CR3 and CR4 is
similar. Namely, they mediate adhesion to ICAM-1 and fibrinogen and phagocytosis of iC3b
opsonised particles. However, from an evolutionary point of view it does not seem economical
to express two different receptors with identical functions by the same cell. Moreover, the intra-
cellular domain of CD11b and CD11c in humans differ in length and amino acid sequence [1,
24, 28], which suggests functional differences betweenCR3 and CR4. Our goal was to dissect
the functions of CR3 and CR4 in the human system.
Previously we analysed the iC3b mediated phagocytosis of human MDDCs and concluded
that CR4 does not take part in this process [17]. In the present work we focused our attention
on adhesion, the other main function of β2 integrins. The importance of this integrinmediated
function is clearly seen in the pathologic condition of lymphocyte adhesion deficiency (LAD)
syndromes type I, II and III, where defective adhesive properties of leukocytes lead to recurrent
and severe life threatening infections [3]. To explore the differences betweenCR3 and CR4 we
tested the adhesive capacity of human monocytes,MDDCs and MDMs on fibrinogen coated
surface.
Fibrinogen has medium affinity to both CD11b and CD11c, suggesting that this ligand
binds to both receptors, which might compete for the ligand. Examination of the affinity of
fibrinogen binding to a 200 amino acid long recombinant CD11b I domain revealed in one
study a Kd of 2,2x10-7M [11], while others have shown an affinity of Kd = 2x10-4M [29]. In the
case of CD11c a Kd = 5x10-5M was determined for fibrinogen [29]. It has also been shown that
both CD11b and CD11c can bind the large variant of fibrinogen (fibrinogen-420), further sup-
porting the idea of simultaneous and competitive binding [7].
determined. The ratio of adhered cells was determined at each lifting force value by dividing the number of
adhered cells in the anti-CD11b or anti-CD11c blocked samples by the number of cells in corresponding
control sample. Data presented are mean +/-SD of three independent donors’ samples. Repeated measures
ANOVA with Bonferroni post-test was used to determine significant differences compared to control at each
force. * = p<0,05, ** = p<0,01.
doi:10.1371/journal.pone.0163120.g004
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Fig 5. Adhesion of RNA silenced macrophages. MDMs were differentiated under conditions where
CD11b or CD11c expression was downregulated by receptor specific siRNA. Control cells were treated with
negative control siRNA. (A) Kinetic curves of adhering cells was recorded by EPIC BT measurement.
Change in refractive index and thereby detected wavelength (Δλ) is plotted against time in the case of CD11b
(dashed line), CD11c (dotted line) or negative control (black line) silenced MDMs of the same donor. The
CD11c/CD18 Dominates Adhesion over CD11b/CD18
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Here, using different techniques we show, that CD11c/CD18 is the main receptor that medi-
ates strong adhesion of MDMs and MDDCs to fibrinogen.We have to keep in mind that the
various methods used in the study reveal different aspects of adhesion. Namely, the static end-
point adhesion assay measures the amount of cells capable of adhering to the substrate, while
the computer controlled micropipette assay measures the strength of adhesion of the same
cells. By blocking CD11c the strength of adherence was strongly reduced in the case of all ana-
lysed cell types, and the contact area of MDMs was significantly smaller than that of the other
cell types. Surprisingly, blocking CD11b results in an even stronger adhesion of MDMs and
MDDCs, along with a larger and more polarized contact area. These data suggest that although
CD11b/CD18 is able to bind fibrinogen [10, 25], it can have a negative role in the adhesion of
these two cell types. Nevertheless, in the case of monocytes, blocking both CD11b and CD11c
decreased the force of adhesion. To resolve this paradoxon, we propose the following hypothe-
sis. Adhesion to fibrinogen is dependent on the total number of CD11b/CD18 and CD11c/
CD18 receptors on the cell surface. In a preliminary experiment we found that the number of
fibrinogen ligands on the adhesive surface is comparable with the total amount of receptors
found on monocytes. Since there is enough ligand available for both receptors, this suggests
that in the case of monocytes, there is no competition between the two receptors for ligand
binding, rather both take part in the adhesion process equally. This idea needs further support
by analysing the CD11b/CD11cmediated adhesion of neutrophils, which express the two
receptors in similar amounts to monocytes. In previous adhesion studies performed on mono-
cytes and neutrophil granulocytes, both CD11b and CD11c mediated adhesion and spreading,
suggesting that the adhesion properties of these cell types are similar [30–34]. However,
MDMs and MDDCs bear far more receptors than the number of accessible ligands on the sur-
faces we constructed, thereby CD11b/CD18 and CD11c/CD18 compete for ligand binding.
Our hypothesis raises further questions about cell adhesion under inflammatory conditions,
when the number of ligands is increased and the amount of receptors also changes [8, 35]. Fur-
thermore the expression and role of CD11d/CD18 in binding to physiological fibrinogen
would be worth to study in more detail, since this receptor was also suggested to be able to bind
this ligand [36].
Adhesion properties of myeloid cells, especiallymonocytes and neutrophils, are of particu-
lar importance in several pathologic conditions. They play an important role in atherosclerosis,
where fibrinogen accumulation is detected under the endothelial layer, furthermore,mono-
cytes were shown to upregulate CD11b and CD11c expression under hypertriglyceridemiccon-
ditions [37, 38] or in rheumatoid arthritis, where elevated CD11b levels and enhanced adhesive
properties of monocytes were already shown [39]. Another pathophysiologic aspect might be
shaded area around each line shows the deviation between the parallel samples. One representative
measurement out of three independent is shown. (B) Average+/-SD Δλ of three independent measurements
was determined at the 30th minute of analysis. Paired t-test was used to compare the effect of CD11b or
CD11c silencing compared to control siRNA treated samples. CD11c silencing was found to decrease Δλ
significantly (p<0,5) (C) Cells were let to adhere for 30min at 37˚C 5%CO2 on plates coated previously with
10μg/ml fibrinogen and blocked with PLL-g-PEG. Filamentous actin was stained with phalloidine-Alexa488
and contact zones were scanned for 200 cells with Olympus IX81 confocal microscope using 60x objective.
Pictures were analysed for the amount of strong and weak actin clusters with ImageJ. CD11b and CD11c
silenced cells were compared to negative control siRNA treated cells. MDMs with reduced CD11b had
significantly more strong clusters and significantly less weak clusters compared to CD11c silenced cells.
Results shown are mean +/- SD of three independent experiments, repeated measures ANOVA with
Bonferroni post-test was used, * = p<0,05, ** = p<0,01. (D) The number of cells adhering with a given force
was determined by the computer controlled micropipette. MDMs with silenced CD11b had significantly more
cells that adhered with strong force compared to negative control siRNA treated cells. Differences in the case
of CD11c silencing were not significant. Results shown are mean +/- SD of three independent experiments,
repeated measures ANOVA with Bonferroni post-test was used, ** = p<0,01, *** = p<0,001.
doi:10.1371/journal.pone.0163120.g005
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related to the rs1143679 (R77H) SNP of the ITGAM (CD11b) gene, that is associated with sys-
temic lupus erythematosus [40]. In this case impaired function of monocytes and MDMs,
MDDCs and neutrophil granulocytes of the risk allele carrying patients was shown [41–44].
Our results shown here suggest that the impaired functionmay be not only the consequence of
compromised CD11b, but could also be caused by the enhanced functionality and ligand bind-
ing capacity of CD11c in the absence of its competitor. This might affect mainly the functions
of macrophages and dendritic cells, and thereby the adaptive immune response generated by
these antigen-presenting cells. The importance of cell adhesion under pathologic conditions is
further highlighted by the role of β2 integrins in forming physiological podosomes and invado-
somes of cancer cells [45–48]. These structuresmediate the invasion and migration of trans-
formed cells by ECM degradation.Moreover it was shown that proteolytic digestion of
fibrinogen, a component of the ECM, enhances its recognition by CD11c on human neutro-
phils [29].
Our recent findings highlighting the difference between the function of human CD11b/
CD18 and CD11c/CD18 facilitates an evenmore detailed analysis of the individual role of
these molecules. The state-of-the-art biophysical methods we used provide a yet unexploited
potential for the analysis of cell functions, like adhesion under steady state and pathological
conditions [19, 20, 49]. The possibility of cell type specific competition or cooperation between
CR3 and CR4 raises several questions regarding integrin functions however the role of addi-
tional receptors in adhesion to fibrinogen cannot be excluded. Still, our results contribute to a
better understanding of the distinct functions of CR3 and CR4.Whether the number and the
type of the ligands they bind, or the ratio of the receptors expressed will determine the outcome
of the interaction, needs further investigation.
Materials and Methods
Ethics statement
The study was conducted in accordance with the ethical guidelines of Declaration of Helsinki
and approved by the Hungarian Medical Research Council Scientific and Research Committee
(ETT TUKEB, permission number: 55627/2012/EKU). Blood samples were purchased from
the Hungarian Blood Transfusion Service,where an informedwritten consent was obtained
from all the donors.
Isolation of monocytes
Monocytes were isolated from buffy coat obtained from healthy donors and provided by the
Hungarian National Blood Transfusion Service.Peripheral bloodmononuclear cells (PBMC)
were separated by Ficoll-Paque PLUS (GE Healthcare Life Sciences) density gradient centrifu-
gation and monocytes were isolated negatively by using the Miltenyi Monocyte Isolation Kit II.
Generation of monocyte-derived macrophages (MDMs) and monocyte-
derived dendritic cells (MDDCs)
To generate MDMs and MDDCsmonocytes were isolated by Miltenyi CD14MicroBeads to
obtain high yield of cells. The isolated cells were cultivated for 5 days in RPMI-1640 medium
(Sigma-Aldrich) supplemented with 10%FCS (Sigma-Aldrich), and Gentamicin antibiotics
(Sigma-Aldrich). To generate MDMs 100 ng/mL rHu GM-CSF (R&D systems) was added to
the isolated monocytes. To generate MDDCs 100 ng/mL rHu GM-CSF (R&D systems) and 15
ng/mL rHu IL-4 (R&D systems) were added to the monocytes [50–52]. Cytokines were sup-
plied on day 3 of differentiation. To identify differentiatedMDMs and MDDCs at day5 of
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cultivation we checked the cultures by flowcytomery:dendritic cells are CD14-, while macro-
phages are CD14+. Furthermore, we analyse the cultures by inverted microscope. Dendritic
cells are non-adherent at day5 with several dendrites in contrast to macrophages, which are
attached to the culture plate, and have a rounded shape without dendrites. The populations
were found to be 95%< homogenous in size, granulation and differentiation stage as deter-
mined by flow cytometricmeasurements.
Determination of absolute receptor numbers on cell surface
Absolute numbers of CD11b and CD11c was determined on the surface of monocytes,MDMs
and MDDCs by using Qifikit (Dako) according to the manufacturers’ instructions. Briefly, cells
were incubated with unlabelledmouse monoclonal antibodies specific for either CD11b or
CD11c at saturating concentrations. After that cells were labelled with goat-anti-mouse FITC
secondary antibody. A calibration curvewas determinedusing beads that carry defined amount
of mouse IgG to specify the correlation between fluorescence intensity and number of antibod-
ies bound. This equation was used to determine the number of bound anti-CD11b or anti-
CD11c antibodies on the cells’ surface. The same unlabelledmouse monoclonal antibodies
were used as for receptor blocking in saturating concentration that was previously titrated by
flow cytometry.
Analysis of integrin conformational state
Integrins’ ligand binding properties highly depend on their conformation. To this end we incu-
bated the cells with monoclonal antibodymAb24 (Hycult Biotech) that recognizes the high
affinity conformation of CD18. After that, cell-boundmAb24 was labelled with goat-anti-
mouse IgG Alexa488 (Molecular Probes, Invitrogen). Samples were analysed on BD FACS
Calibur flowcytometer using CellQuest software for data acquisition and FCS Express 3.0 soft-
ware for data analysis. We compared the cells mAb24 staining in the media used for adhesion
at 4°C and 37°C compared to isotype control staining in each case.
Blocking of CD11b/CD18 and CD11c/CD18 by antibodies
The role of CD11b/CD18 and CD11c/CD18 in the adhesion to fibrinogenwas analysed by
comparing the adhesive properties of monocytes,MDMs and MDDCs treated with either anti-
CD11b antibody (monoclonal mIgG1 clone TMG6-5, provided by István Andó at BRC Szeged,
Hungary) or anti-CD11c antibody (monoclonal mIgG1 clone 3.9, Biolegend). Both antibodies
are specific for the ligand binding domain of the integrins and were used in sterile, azide-free
form at saturating concentration previously titrated by flow cytometry. Cells were incubated
with the receptor-specific antibodies for 30min at 4°C and used in adhesion studies without
washing. Since unoccupied integrins are known to recycle to the cell surface, and would
decrease the efficiencyof blocking, unbound antibodies were not washed away. Cells were
incubated in the presence of FcR blocking reagent (Miltenyi Biotech), and the effect of receptor
specific antibodies was compared to untreated samples that were incubated only with FcR
blocking reagent.
RNA silencing in macrophages
RNA silencing was performed according to the method of Prechtel [53]. We used commercially
available predesignedQiagen (Germany) AllStar Negative control siRNA and Qiagen Genome
Wide predesigned siRNA for CD11c (Hs_ITGAX_6) and CD11b (Hs_ITGAM_5). Cells were
transfected on day3 and day5 of differentiation with 20μg siRNA to generate CD11c silenced,
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CD11b silenced or negative control silencedMDMs at day6. The expression of CD11c and
CD11b was analysed on day6 by cytofluorimetryand subsequent experiments were carried out
on the same day.
Analysis of adhesion by confocal microscopy
Wells were coated by 10μg/ml fibrinogen in phosphate buffered saline solution (PBS) for 1
hour at 37°C. After that wells were washed 2 times with PBS and free surfaces were blocked
with synthetic copolymer poly(L-lysine)-graft-poly(ethylene glycol) (PLL-g-PEG, SuSoS AG)
for 30min at RT. After washing 2 times with PBS, 5x104 cells in RPMI1640-10%FCSwere
immediately transferred to the wells and let to adhere for 30min at 37°C in a CO2 incubator.
After the incubation samples were fixed by 2% paraformaldehyde (Sigma-Aldrich) for 10min
and unbound cells were removed by extensive washing 2 times with PBS.
The number of adhered cells was determined by staining the nuclei with Draq5 (BioLegend)
diluted 2000x in PBS and incubated for 15min at RT. Samples were analysed by Olympus IX81
confocal microscope (10x objective) and FluoView500 software. 4 representative fields were
scanned in each well of triplicate sample, thereby the number of adhered cells was determined
in 12 parallel fields for each treatment by ImageJ software.
To analyse the contact zone of the cells actin cytoskeleton was stained with phalloidin-
Alexa488 (Molecular Probes, Invitrogen). The probe was 100x diluted in PBS-0,1% Triton-X
(Sigma-Aldrich) and cells were stained for 5min at 37°C and after that washed 3 times with
PBS. Samples were analysed by Olympus IX81 confocal microscope (60x objective) and Fluo-
View500 software. Pictures were further analysed by ImageJ software.
Analysis of adhesion with the computer-controlled micropipette
Single cell adhesion force was analysed with an imaging-based automated micropipette (Cell-
Sorter) as describedpreviously [49, 54]. Briefly, Petri dishes were coated by 10μg/ml fibrinogen
in phosphate buffered saline solution (PBS) for 1 hour at 37°C. Dishes were washed 2 times
with PBS and the surface was blocked with the synthetic copolymer poly(L-lysine)-graft-poly
(ethylene glycol) (PLL-g-PEG, SuSoS AG) in order to inhibit non-specific cell adhesion for 30
min at RT. After washing the Petri dish again with PBS, 7,5x104 cells in RMPI-10% FCS were
placed onto the coated surface. Cells were incubated for 30 minutes at 37°C in 5% CO2 atmo-
sphere. Cultures were washed 3–4 times with Hanks’ Balanced Salt solution with sodium bicar-
bonate without phenol red buffer (HBSS, Sigma) to remove floating cells. Region of interest
(ROI) of the Petri dish was scanned by a motorizedmicroscope (Zeiss Axio ObserverA1)
equipped with a digital camera (Qimaging Retiga 1300 cooledCCD). Cells were automatically
recognizedby the CellSorter software. To minimize the duration of the measurement, the
shortest path of the micropipette was calculated by software [55]. Individual cells were visited
and probed by the glass micropipette. Micropipette with an aperture of 70 μm approached the
surface to a distance of 10 μm. Vacuum was generated in a standard syringe connected to the
micropipette via a high speed normally closed fluid valve. To probe cell adhesion the valve was
opened for 20 ms generating a precisely controlled fluid flow and corresponding hydrodynamic
lifting force acting only on the targeting cell. The hydrodynamic lifting force was calculated by
running computer simulation solving the Navier-Stokes equation in a geometry corresponding
to the experimental setup [49]. After each cycle of the adhesion force measurement the ROI of
the Petri dish was scanned again, and the vacuumwas increased to the next level. The micropi-
pette visited again each location determined after the initial scan. Suction force was increased
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as long as most of the cells were removed. We counted the number of cells in the images before
and after each cycle of the adhesion force measurement and calculated the ratio of still adhering
cells of the population placed onto the surface at the beginning of the experiment.
Analysis of adhesion by EPIC BT biosensor measurement
Kinetic of the adhesion was measured on the Corning EPIC biosensor as described previ-
ously in details [20]. Briefly, each well of a standard microtiter plate contains an optical grat-
ing at its bottom which permits the illuminating light to be incoupled in the waveguide.
Light beams in the waveguide interfere with each other; destructive interference precludes
wave guiding, while constructive interference leads to resonance and to the excitation of a
guided light mode. The latter can be achieved only at a discrete illuminating wavelength,
called resonant wavelength (λ). The guided light mode generates an exponentially decaying
evanescent field in a 100–200 nm thick layer over the sensor, which probes the local refrac-
tive index (RI) at this interface. Any process accompanied by RI-variations in this layer (bulk
RI change, molecular adsorption, cell spreading, or dynamic redistribution in the cells)
untunes the resonance by altering the phase-shift of the propagating light when it is reflected
from the interface (leading to destructive interference at the original resonance wavelength).
The primary output of the EPIC sensor is then the shift of the resonant wavelength, Δλ.
Wells were coated by 10μg/ml fibrinogen in phosphate buffered saline for 1 hour at 37°C.
After that wells were washed 3 times with PBS and free surfaces were blocked with synthetic
copolymer poly(L-lysine)-graft-poly(ethylene glycol) (PLL-g-PEG, SuSoS AG) for 30min at
RT. After washing 3 times with PBS, 2x104 cells in RPMI-10%FCS were immediately trans-
ferred to the wells and the registration of the Δλ was continuously monitored throughout the
experiment (120min).
Statistical analysis
Two-way ANOVA with Bonferroni post-test or paired t-test was used to determine significant
differences between the differently treated groups, p<0,05 was considered significant. In each
case a minimum of 3 independent donor’s data were analysed.
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